Discovery | Charles River

Join our December 12 webinar to explore how an #mRNA-encoded #antibody platform could accelerate antibody therapies to clinic. Presenters include Roxana Redis and Dan Rocca from Charles River and Sourav Mukherjee, PhD from Vernal Biosciences. Register now: https://okt.to/9hxqo0

Logica accelerates drug discovery by transforming ideas into optimized candidates: Our approach starts with precise target identification, followed by data-driven lead discovery, and culminates in the delivery of high-quality preclinical candidates. With AI-powered insights and world-renowned wet lab expertise, we streamline each stage to deliver results faster and more efficiently. Discover how we’re advancing and derisking #drugdiscovery. https://okt.to/VKgIGN #Logica

Thank you for joining us at Neuroscience 2024. This years program included numerous scientific posters and presentations outlining the latest data, insights, and tools to accelerate your neuroscience research. https://okt.to/VgoWZF #SfN24 #SfN2024

In a recent publication, our in vitro ADME scientist Csilla Ambrus and her team showcase how the reliability of brain permeability prediction based on data can be improved, using optimized transporter assays and appropriately chosen in vivo-in vitro extrapolation methods. Read about their key findings: https://okt.to/23R4aJ

We are excited to announce that Lundbeck is using Logica’s AI-powered platform to advance research into central nervous system (CNS) disorders. “Partnering with Logica will allow us to use a unique tool set, including AI-driven approaches, to overcome drug design challenges which often slow down the translation of promising targets into drug candidates.” - Tarek Samad, Senior Vice President and Head of Global Research at Lundbeck. Explore how this partnership for good is set to break new ground in CNS drug discovery. https://okt.to/t6Nhel #AI #CNS #DrugDiscovery #Logica

#Immunotoxicity represents a 10-20% failure rate in clinical trials of new therapeutics. Watch this webinar to learn how immunogenicity, immunotoxicity, and specificity/off-target screening can be performed at the preclinical stage. Watch on-demand. https://okt.to/QY7byx

Explore an #antibody discovery case study on targeting antigens with highly homologous family members in our on-demand webinar. Charles River’s Kalyani Mondal covers how a diverse phage library and well-designed panning strategy helps against challenging antibody targets. Watch now: https://okt.to/qw3Wrg

Go inside the practical application of #AI in #DrugDiscovery with our detailed guide. Understand how Logica combines AI with immense wet lab expertise to accelerate innovation and enhance success rates. Explore our approach for a deeper insight into the future of drug development. https://okt.to/xn1jvz

Using our #Retrogenix? Cell Microarray platform to identify the receptor of their AAV9 therapeutic, Affinia Therapeutics also leveraged our gene therapy CDMO capabilities for a complete end-to-end experience. Access the case study now to see how they did it. https://okt.to/b5O4M0 #genetherapy

Listen to our recent podcast to learn more about the advancement in #neuroscience research using complex multicell models to better mimic human brain physiology in CNS drug discovery. Visit our Big4Bio podcast series here. https://okt.to/0cohVA